





* National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee
Department of Pediatrics and Strong Childrens Research Center, University of Rochester School of Medicine and Dentistry, Rochester, New York
|| Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee
¶ National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Objective. Respiratory syncytial virus (RSV), influenza virus, and parainfluenza viruses (PIV) cause significant morbidity in young children. Although only influenza virus infection and illness is currently vaccine-preventable, vaccines are under development for RSV and PIV. We established a prospective, active population-based surveillance network to provide precise estimates of hospitalization rates for viral acute respiratory illness (ARI) in young children and to measure the potential impact of enhanced vaccine usage on these rates.
Methods. Prospective, active population-based surveillance was conducted in young children who were hospitalized for ARI from October 1, 2000, to September 30, 2001, in Monroe County, New York (Rochester area) and Davidson County, Tennessee (Nashville area). Eligible children younger than 5 years were those who resided in surveillance counties and were hospitalized for febrile or acute respiratory illness. Viral culture and polymerase chain reaction identified viruses from nasal and throat samples obtained from all surveillance children. We measured population-based rates of hospitalization for RSV, influenza virus, and PIV as well as demographic, clinical, and risk factor assessment for each virus.
Results. Of 812 eligible hospital admissions, 592 (73%) children were enrolled. Of the enrolled children, RSV was identified in 20%, influenza in 3%, PIV in 7%, other respiratory viruses in 36%, and no detectable virus in 39%. Population-based rates of ARI hospitalizations in children younger than 5 years were 18 per 1000. Virus-positive hospitalization rates per 1000 children were 3.5 for RSV, 1.2 for PIV, and 0.6 for influenza virus. Younger age (particularly <1 year), black and Hispanic race/ethnicity, male gender, and presence of chronic underlying illness were associated with higher hospitalization rates.
Conclusions. This study confirms that children younger than 5 years and particularly children younger than 1 year have a high burden of hospitalization from RSV, influenza, and PIV. The enhanced use of influenza vaccine and the development of RSV and PIV vaccines have the potential to reduce markedly the pediatric morbidity from ARIs.
Key Words: influenza RSV parainfluenza population-based hospitalizations
Abbreviations: ARI, acute respiratory illness RSV, respiratory syncytial virus PIV, parainfluenza virus RT-PCR, reverse transcription-polymerase chain reaction NVSN, New Vaccine Surveillance Network CDC, Centers for Disease Control and Prevention
This article has been cited by other articles:
![]() |
Committee on Infectious Diseases Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2007-2008 Pediatrics, April 1, 2008; 121(4): e1016 - e1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Kearns, S. Lu, L. Maganti, X. Li, E. Migoya, T. Ahmed, B. Knorr, and T. F. Reiss Pharmacokinetics and Safety of Montelukast Oral Granules in Children 1 to 3 Months of Age With Bronchiolitis J. Clin. Pharmacol., April 1, 2008; 48(4): 502 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Yorita, R. C. Holman, J. J. Sejvar, C. A. Steiner, and L. B. Schonberger Infectious Disease Hospitalizations Among Infants in the United States Pediatrics, February 1, 2008; 121(2): 244 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Miller, M. R. Griffin, K. M. Edwards, G. A. Weinberg, P. G. Szilagyi, M. A. Staat, M. K. Iwane, Y. Zhu, C. B. Hall, G. Fairbrother, et al. Influenza Burden for Children With Asthma Pediatrics, January 1, 2008; 121(1): 1 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-A. S. Harris, W. C. Huskins, J. M. Langley, J. D. Siegel, and for the Pediatric Special Interest Group of the So Health Care Epidemiology Perspective on the October 2006 Recommendations of the Subcommittee on Diagnosis and Management of Bronchiolitis Pediatrics, October 1, 2007; 120(4): 890 - 892. [Full Text] [PDF] |
||||
![]() |
S. E. Coffin, T. E. Zaoutis, A. B. W. Rosenquist, K. Heydon, G. Herrera, C. B. Bridges, B. Watson, R. Localio, R. L. Hodinka, and R. Keren Incidence, Complications, and Risk Factors for Prolonged Stay in Children Hospitalized With Community-Acquired Influenza Pediatrics, April 1, 2007; 119(4): 740 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Boogaard, A. R. Hulsmann, L. van Veen, A. A. P. H. Vaessen-Verberne, Y. N. Yap, A. J. Sprij, G. Brinkhorst, B. Sibbles, T. Hendriks, S. W. W. Feith, et al. Recombinant Human Deoxyribonuclease in Infants With Respiratory Syncytial Virus Bronchiolitis Chest, March 1, 2007; 131(3): 788 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Shuler, M. Iwamoto, C. B. Bridges, M. Marin, R. Neeman, P. Gargiullo, T. A. Yoder, H. L. Keyserling, and P. D. Terebuh Vaccine Effectiveness Against Medically Attended, Laboratory-Confirmed Influenza Among Children Aged 6 to 59 Months, 2003-2004 Pediatrics, March 1, 2007; 119(3): e587 - e595. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Grijalva, K. A. Poehling, K. M. Edwards, G. A. Weinberg, M. A. Staat, M. K. Iwane, W. Schaffner, and M. R. Griffin Accuracy and Interpretation of Rapid Influenza Tests in Children Pediatrics, January 1, 2007; 119(1): e6 - e11. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ampofo, P. H. Gesteland, J. Bender, M. Mills, J. Daly, M. Samore, C. Byington, A. T. Pavia, and R. Srivastava Epidemiology, Complications, and Cost of Hospitalization in Children With Laboratory-Confirmed Influenza Infection Pediatrics, December 1, 2006; 118(6): 2409 - 2417. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Pelletier, J. M. Mansbach, and C. A. Camargo Jr Direct Medical Costs of Bronchiolitis Hospitalizations in the United States Pediatrics, December 1, 2006; 118(6): 2418 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Szilagyi, M. R. Griffin, L. P. Shone, R. Barth, Y. Zhu, S. Schaffer, S. Ambrose, J. Roy, K. A. Poehling, K. M. Edwards, et al. The Impact of Conjugate Pneumococcal Vaccination on Routine Childhood Vaccination and Primary Care Use in 2 Counties Pediatrics, October 1, 2006; 118(4): 1394 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Al-Toum, S. Bdour, and H. Ayyash Epidemiology and Clinical Characteristics of Respiratory Syncytial Virus Infections in Jordan J Trop Pediatr, August 1, 2006; 52(4): 282 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Poehling, K. M. Edwards, G. A. Weinberg, P. Szilagyi, M. A. Staat, M. K. Iwane, C. B. Bridges, C. G. Grijalva, Y. Zhu, D. I. Bernstein, et al. The underrecognized burden of influenza in young children. N. Engl. J. Med., July 6, 2006; 355(1): 31 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Poehling, Y. Zhu, Y.-W. Tang, and K. Edwards Accuracy and Impact of a Point-of-Care Rapid Influenza Test in Young Children With Respiratory Illnesses Arch Pediatr Adolesc Med, July 1, 2006; 160(7): 713 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. T. Bourgeois, C. Valim, J. C. Wei, A. J. McAdam, and K. D. Mandl Influenza and Other Respiratory Virus-Related Emergency Department Visits Among Young Children Pediatrics, July 1, 2006; 118(1): e1 - e8. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Divekar, D. M. W. Zaiss, F. E.-H. Lee, D. Liu, D. J. Topham, A. J. A. M. Sijts, and T. R. Mosmann Protein Vaccines Induce Uncommitted IL-2-Secreting Human and Mouse CD4 T Cells, Whereas Infections Induce More IFN-{gamma}-Secreting Cells J. Immunol., February 1, 2006; 176(3): 1465 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
Brief Report: Respiratory Syncytial Virus Activity--United States, 2004-2005 JAMA, January 18, 2006; 295(3): 267 - 268. [Full Text] [PDF] |
||||
![]() |
J S Nguyen-Van-Tam Influenza related hospital admissions in children: evidence about the burden keeps growing but the route to policy change remains uncertain Arch. Dis. Child., January 1, 2006; 91(1): 5 - 7. [Full Text] [PDF] |
||||
![]() |
N. Bhat, J. G. Wright, K. R. Broder, E. L. Murray, M. E. Greenberg, M. J. Glover, A. M. Likos, D. L. Posey, A. Klimov, S. E. Lindstrom, et al. Influenza-Associated Deaths among Children in the United States, 2003-2004 N. Engl. J. Med., December 15, 2005; 353(24): 2559 - 2567. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Allander, M. T. Tammi, M. Eriksson, A. Bjerkner, A. Tiveljung-Lindell, and B. Andersson From The Cover: Cloning of a human parvovirus by molecular screening of respiratory tract samples PNAS, September 6, 2005; 102(36): 12891 - 12896. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Ritzwoller, C. B. Bridges, S. Shetterly, K. Yamasaki, M. Kolczak, and E. K. France Effectiveness of the 2003-2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 vs 2 Doses Pediatrics, July 1, 2005; 116(1): 153 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Humiston, E. B. Lerner, E. Hepworth, T. Blythe, and J. G. Goepp Parent Opinions About Universal Influenza Vaccination for Infants and Toddlers Arch Pediatr Adolesc Med, February 1, 2005; 159(2): 108 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Thompson, D. K. Shay, E. Weintraub, L. Brammer, C. B. Bridges, N. J. Cox, and K. Fukuda Influenza-Associated Hospitalizations in the United States JAMA, September 15, 2004; 292(11): 1333 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Meissner and M. B. Rennels Unpredictable Patterns of Viral Respiratory Disease in Children Pediatrics, June 1, 2004; 113(6): 1814 - 1816. [Full Text] [PDF] |
||||